Učitavanje...

Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction via ROS Damage and Upregulation of HIF-1α

Combined androgen blockade using bicalutamide (Bic) is a therapeutic choice for treating prostate cancer (PCa). However, even at regular clinical dosages, Bic frequently shows adverse effects associated with cardiovascular and renal damage. Previously, we found that Bic selectively damaged mesangial...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Chen, Kuan-Chou, Chen, Chang-Rong, Chen, Chang-Yu, Tzou, Kai-Yi, Peng, Chiung-Chi, Peng, Robert Y.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7247665/
https://ncbi.nlm.nih.gov/pubmed/32403414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093400
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!